5-Hydroxymethyl-2′-deoxyuridine, but not temozolomide, enhances the selective synthetic lethality in BRCA1 and BRCA2-deficient cells caused by PARP inhibition

被引：1
|
作者：
Clement, Jean [1 ]
Nakamura, Jun [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-4486
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4486
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The DNA strand breaking nucleoside analogue sapacitabine sensitizes Brca2-deficient ovarian cancer cells and synergizes with PARP inhibitors
    Liu, Xiaojun
    Jiang, Yingjun
    Nowak, Billie
    Qiang, Bethany
    Cheng, Nancy
    Plunkett, William
    CANCER RESEARCH, 2016, 76
  • [42] Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition
    Diar Aziz
    Neil Portman
    Kristine J. Fernandez
    Christine Lee
    Sarah Alexandrou
    Alba Llop-Guevara
    Zoe Phan
    Aliza Yong
    Ashleigh Wilkinson
    C. Marcelo Sergio
    Danielle Ferraro
    Dariush Etemadmoghadam
    David D. Bowtell
    Violeta Serra
    Paul Waring
    Elgene Lim
    C. Elizabeth Caldon
    npj Breast Cancer, 7
  • [43] Inhibition of poly(ADP-ribose) glycohydrolase (PARG) specifically kills BRCA2-deficient tumor cells
    Fathers, Catherine
    Drayton, Ross M.
    Solovieva, Svetlana
    Bryant, Helen E.
    CELL CYCLE, 2012, 11 (05) : 990 - 997
  • [44] PARP inhibitor synthetic lethality in ATM biallelic mutant cancer cell lines is associated with BRCA1/2 and RAD51 downregulation
    Muvaffak, Asli
    Coleman, Kevin G.
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [45] RAD52 aptamer regulates DNA damage repair and STAT3 in BRCA1/BRCA2-deficient human acute myeloid leukemia
    Xu, Yichuan
    Lin, Yansi
    Luo, Yuxuan
    Yang, Yanling
    Long, Bing
    Fang, Zhigang
    Liu, Lingling
    Zhang, Jingwen
    Zhang, Xiangzhong
    ONCOLOGY REPORTS, 2020, 44 (04) : 1455 - 1466
  • [46] Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells (vol 12, e80254, 2023)
    Martino, Julieta
    Siri, Sebastian Omar
    Calzetta, Nicolas Luis
    Paviolo, Natalia Soledad
    Garro, Cintia
    Pansa, Maria F.
    Carbajosa, Sofia
    Brown, Aaron C.
    Bocco, Jose Luis
    Gloger, Israel
    Drewes, Gerard
    Madauss, Kevin P.
    Soria, Gaston
    Gottifredi, Vanesa
    ELIFE, 2023, 12
  • [47] IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors
    Maifrede, Silvia
    Martin, Kayla
    Podszywalow-Bartnicka, Paulina
    Sullivan-Reed, Katherine
    Langer, Samantha K.
    Nejati, Reza
    Dasgupta, Yashodhara
    Hulse, Michael
    Gritsyuk, Daniel
    Nieborowska-Skorska, Margaret
    Lupey-Green, Lena N.
    Zhao, Huaqing
    Piwocka, Katarzyna
    Wasik, Mariusz A.
    Tempera, Italo
    Skorski, Tomasz
    MOLECULAR CANCER RESEARCH, 2017, 15 (08) : 967 - 972
  • [48] Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells
    Sullivan-Reed, Katherine
    Bolton-Gillespie, Elisabeth
    Dasgupta, Yashodhara
    Langer, Samantha
    Siciliano, Micheal
    Nieborowska-Skorska, Margaret
    Hanamshet, Kritika
    Belyaeva, Elizaveta A.
    Bernhardy, Andrea J.
    Lee, Jaewong
    Moore, Morgan
    Zhao, Huaqing
    Valent, Peter
    Matlawska-Wasowska, Ksenia
    Muschen, Markus
    Bhatia, Smita
    Bhatia, Ravi
    Johnson, Neil
    Wasik, Mariusz A.
    Mazin, Alexander, V
    Skorski, Tomasz
    CELL REPORTS, 2018, 23 (11): : 3127 - 3136
  • [49] Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Leukemia Cells
    Sullivan, Katherine
    Bolton-Gillespie, Elisabeth
    Dasgupta, Yashodhara
    Langer, Samantha
    Siciliano, Micheal
    Nieborowska-Skorska, Margaret
    Zhao, Huaqing
    Valent, Peter
    Skorski, Tomasz
    BLOOD, 2017, 130
  • [50] The effect of PARP inhibition on BAX/BAK independent synthetic lethality of BRCA1-deficient non-small cell lung cancer
    Paul, I.
    Savage, K.
    Lamers, E.
    Gately, K.
    O'Byrne, K. J.
    Blayney, J. K.
    Kerr, K. M.
    Sheaff, M.
    Richard, D. J.
    Hamilton, P. W.
    James, J.
    Quinn, J. E.
    Fennell, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345